The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.
Abstract
Cytomegalovirus (CMV) infection and disease are important causes of morbidity and mortality in transplant recipients. For the purpose of developing consistent reporting of CMV outcomes in clinical trials, definitions of CMV infection and disease were developed and most recently published in 2002. Since then, there have been major developments in its diagnosis and management. Therefore, the CMV Drug Development Forum consisting of scientists, clinicians, regulators, and industry representatives has produced an updated version incorporating recent knowledge with the aim to support clinical research and drug development. The main changes compared to previous definitions are the introduction of a "probable disease" category and to incorporate quantitative nucleic acid testing in some end-organ disease categories. As the field evolves, the need for updates of these definitions is clear, and collaborative efforts between scientists, regulators, and industry can provide a platform for this work.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
Ljungman, P., Griffiths, P., & Paya, C. (2002) · Clinical Infectious Diseases · doi:10.1086/339329 · Cited by 1,234
Self-citationSchmidt, G. M., Horak, D. A., Niland, J. C., Duncan, S. R., Forman, S. J., Zaia, J. A., & the City of Hope–Stanford–Syntex CMV Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199104113241501 · Cited by 616
Humar, A., Lebranchu, Y., Vincenti, F., Blumberg, E. A., Punch, J. D., Limaye, A. P., Abramowicz, D., Jardine, A. G., Voulgari, A. T., Ives, J., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03074.x · Cited by 504
Griffiths, P. D., Stanton, A., McCarrell, E., Smith, C., Osman, M., Harber, M., Davenport, A., Jones, G., Wheeler, D. C., O'Beirne, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60136-0 · Cited by 389
Self-citationLetermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
Chemaly, R. F., Ullmann, A. J., Stoelben, S., Richard, M. P., Bornhäuser, M., Groth, C., Einsele, H., Silverman, M., Mullane, K. M., Brown, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1309533 · Cited by 378
CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
Marty, F. M., Winston, D. J., Rowley, S. D., Vance, E., Papanicolaou, G. A., Mullane, K. M., Brundage, T. M., Robertson, A. T., Godkin, S., Momméja-Marin, H., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303688 · Cited by 374
Self-citationMarty, F. M., Ljungman, P., Papanicolaou, G. A., Winston, D. J., Chemaly, R. F., Strasfeld, L., Young, J.-A. H., Rodriguez, T., Maertens, J., Schmitt, M., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70024-x · Cited by 350
Self-citationKharfan-Dabaja, M. A., Boeckh, M., Wilck, M. B., Langston, A. A., Chu, A. H., Wloch, M. K., Guterwill, D. F., Smith, L. R., Rolland, A. P., & Kenney, R. T. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70344-9 · Cited by 232
Self-citationAccelerating Drug Development Through Collaboration: The Hepatitis C Drug Development Advisory Group
Hutchison, C. A., Kwong, A. D., Ray, S. C., Struble, K. A., Swan, T., & Miller, V. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.113 · Cited by 16
Self-citationMiller, V. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.140 · Cited by 15
Self-citation
Cited by
Kotton, C. N., Kumar, D., Caliendo, A. M., Huprikar, S., Chou, S., Danziger-Isakov, L., & Humar, A. (2018) · Transplantation · doi:10.1097/tp.0000000000002191 · Cited by 1,152
Razonable, R. R., & Humar, A. (2019) · Clinical Transplantation · doi:10.1111/ctr.13512 · Cited by 753
Self-citationPathogenesis of human cytomegalovirus in the immunocompromised host
Griffiths, P., & Reeves, M. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00582-z · Cited by 610
Self-citationDiagnosis of severe respiratory infections in immunocompromised patients
Azoulay, E., Russell, L., Van de Louw, A., Metaxa, V., Bauer, P., Povoa, P., Montero, J. G., Loeches, I. M., Mehta, S., Puxty, K., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05906-5 · Cited by 346
McDonald, G. B., Sandmaier, B. M., Mielcarek, M., Sorror, M., Pergam, S. A., Cheng, G.-S., Hingorani, S., Boeckh, M., Flowers, M. D., Lee, S. J., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m19-2936 · Cited by 285
Self-citationNeofytos, D., Chatzis, O., Nasioudis, D., Boely Janke, E., Doco Lecompte, T., Garzoni, C., Berger, C., Cussini, A., Boggian, K., Khanna, N., et al. (2018) · Transplant Infectious Disease · doi:10.1111/tid.12898 · Cited by 108
Lee, K. H., Kwon, D. E., Do Han, K., La, Y., & Han, S. H. (2020) · BMC Neurology · doi:10.1186/s12883-020-01776-3 · Cited by 35
Metadata
- Authors
- Ljungman, P., Boeckh, M., Hirsch, H. H., Josephson, F., Lundgren, J., Nichols, G., Pikis, A., Razonable, R. R., Miller, V., & Griffiths, P. D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-09-28
- Volume
- 64
- Issue
- 1
- Pages
- 87-91
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2524753328
- Cited by
- 955
- References
- 10
- FWCI
- 56.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.